Johnson & Johnson Announces Quarterly Dividend for First Quarter 2025

Rhea-AI Summary

Johnson & Johnson (NYSE: JNJ) has announced its quarterly dividend for the first quarter of 2025. The Board of Directors has declared a cash dividend of $1.24 per share on the company's common stock. The dividend will be payable on March 4, 2025, to shareholders of record at the close of business on February 18, 2025. The ex-dividend date is set for February 18, 2025.

Positive

• Maintains consistent quarterly dividend payment of $1.24 per share

Negative

• None.

Insights

Financial Analyst

The dividend announcement of $1.24 per share maintains J&J's consistent quarterly payout, marking the company's 61st consecutive year of dividend increases. This stability in dividend distribution, particularly from a Dividend King like J&J, signals robust financial health and steady cash flow generation. The dividend yield stands at approximately 3.0% based on current share price, positioning it competitively among healthcare sector peers. The timing aligns with typical quarterly distribution patterns and the ex-dividend date of February 18 gives investors clear parameters for qualification. While this represents business as usual for J&J, the consistent dividend policy remains a cornerstone of their shareholder return strategy, especially significant given their recent consumer healthcare spinoff of Kenvue. The maintained dividend level post-spinoff demonstrates J&J's confidence in their pharmaceutical and medical device segments' ability to generate sustainable cash flows.

Market Research Analyst

This dividend announcement, while routine, carries strategic significance in the current market environment. With a market capitalization of $348.19 billion, J&J's commitment to maintaining its dividend speaks to the defensive nature of the stock amid economic uncertainties. The pharmaceutical giant's dividend policy has historically provided a reliable income stream that typically outpaces inflation. In the broader healthcare sector context, this $1.24 per share quarterly payout helps maintain J&J's position as a blue-chip stalwart, particularly appealing to income-focused investors in a high interest rate environment. The dividend's sustainability is backed by J&J's diverse revenue streams and strong market position in both pharmaceuticals and medical devices, making it a benchmark for stability in healthcare sector investments.

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)-- Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a cash dividend for the first quarter of 2025 of $1.24 per share on the company’s common stock. The dividend is payable on March 4, 2025 to shareholders of record at the close of business on February 18, 2025. The ex-dividend date is February 18, 2025.

About Johnson & Johnson

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com/.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250102880411/en/

Media contact:

media-relations@its.jnj.com



Investor contact:

investor-relations@its.jnj.com

Source: Johnson & Johnson

FAQ

What is Johnson & Johnson's (JNJ) dividend amount for Q1 2025?

Johnson & Johnson's dividend for Q1 2025 is $1.24 per share.

When is the payment date for JNJ's Q1 2025 dividend?

The Q1 2025 dividend payment date is March 4, 2025.

What is the ex-dividend date for JNJ's Q1 2025 dividend?

The ex-dividend date is February 18, 2025.

What is the record date for JNJ's Q1 2025 dividend?

The record date is February 18, 2025, at the close of business.